Kamada (KMDA) continues to expect to generate fiscal year 2025 total revenues in the range of $178 million to $182 million, and adjusted EBITDA in the range of $38 million to $42 million, representing a year-over-year increase of approximately 12% in revenues and 17% in adjusted EBITDA based on the mid-point of the 2025 guidance.
Protect Your Portfolio Against Market Uncertainty
- Discover companies with rock-solid fundamentals in TipRanks' Smart Value Newsletter.
- Receive undervalued stocks, resilient to market uncertainty, delivered straight to your inbox.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on KMDA:
- Kamada to Release Q1 2025 Financial Results on May 14
- Kamada Launches Post-Marketing Research Program for CYTOGAM
- Kamada announces launch of post-marketing research program for CYTOGAM
- Kamada Announces Tax Ruling on Special Cash Dividend
- Kamada provides update on withholding tax procedures on special cash dividend